References

“I also wanted to let you know what an unbelievable job (the Core Manager) did on my submission.  We had a list minute glitch and she saved the day.  I really, really, really appreciate it.  She really came through in a huge way!” – Karen Emmons, July 2004

“Thanks so much for meeting with me. I found the information very helpful and I also think that HPHC will be a good match. I will bring back the discussions to our group and keep you posted.” – Vish Viswanath, August 2004

“Thank you so much for the additional information and your flexibility here…This is very helpful to us.” – Andrea Gurmankin, January 2005

Clinical and Pathological Predictors for Recurrence after DCIS  - Stuart Schnitt (BIDMC)
Connection: Facilitated contact between the DF/HCC investigators and the CRN, identified collaborators.
Access: Provided access to a large CRN population resulting in a study of 3,600 women with DCIS (the  largest study of its type ever undertaken).
Support: Provided preliminary data needed for the preparation of the proposal.
Results: NCI proposal funded with budget > $3.5 million. This study is the first to explore the link between basic and population research within our community practice settings.

Cancer Prevention Through Health Centers (Healthy Directions) - K. Emmons (DFCI)
Connection: Matched investigators to HVMA collaborator.
Access:     Provided access to needed population of approximately 2,000 patients (40% minority) and 100 physicians.  
Support: Met with investigators, provided consultation services, facilitated contact with 10 HVMA sites
Results: NCI cancer prevention proposal funded with budget > $2.9 million.
Intervention led to 3 publications. Two pilot studies have evolved and a follow-up RO1 will be resubmitted in July 2005.

National Lung Screening Trial – P. Costello (BWH)
Connection: Identified a local co-investigator and facilitated contact with members of HVMA.
Access: Obtained list of 9,000 HVMA smokers and provided contact information for those members.
Support: Completed required IRB/HIPAA protocols.
Result: Research team able to meet its recruitment goal within 6 weeks.

• 
• 
  • Biostatistics
  • Cancer Pharmacology
  • Cancer Proteomics
  • Cell Manipulation
  • Community Practice
    • Services
    • Pricing
    • References
    • Feedback
    • Contact
  • Cytogenetics (Pathology)
  • DNA Resource
  • Health Communication
  • High-Throughput Polymorphism
  • Monoclonal Antibody
  • Pathology Specimen Locator
  • Rapid Case Identification
  • Research Pharmacy
  • Rodent Histopathology (Pathology)
  • Specialized Histopathology Services (Pathology)
  • Tissue Microarray and Imaging (Pathology)
  • Tumor Imaging Metrics
  • Vector
• 
• 
• 
• 
•